Several other circulating proteins have shown diagnostic and prognostic value for melanoma, including S100B, C reactive protein (CRP) and melanoma-inhibiting activity (MIA) protein (reviewed in [21]) but all have limitations in routine clinical use. This evidence concerns the gene S100B and melanoma.